185 related articles for article (PubMed ID: 8619571)
1. In vitro activities of antimicrobial combinations against Stenotrophomonas (Xanthomonas) maltophilia.
Poulos CD; Matsumura SO; Willey BM; Low DE; McGeer A
Antimicrob Agents Chemother; 1995 Oct; 39(10):2220-3. PubMed ID: 8619571
[TBL] [Abstract][Full Text] [Related]
2. In vitro susceptibility of Stenotrophomonas maltophilia to various antimicrobial combinations.
Krueger TS; Clark EA; Nix DE
Diagn Microbiol Infect Dis; 2001; 41(1-2):71-8. PubMed ID: 11687317
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Trimethoprim/Sulfamethoxazole (SXT), Minocycline, Tigecycline, Moxifloxacin, and Ceftazidime Alone and in Combinations for SXT-Susceptible and SXT-Resistant Stenotrophomonas maltophilia by In Vitro Time-Kill Experiments.
Wei C; Ni W; Cai X; Zhao J; Cui J
PLoS One; 2016; 11(3):e0152132. PubMed ID: 26999818
[TBL] [Abstract][Full Text] [Related]
4. Comparison of different antimicrobial susceptibility testing methods for Stenotrophomonas maltophilia and results of synergy testing.
Gülmez D; Cakar A; Sener B; Karakaya J; Hasçelik G
J Infect Chemother; 2010 Oct; 16(5):322-8. PubMed ID: 20449623
[TBL] [Abstract][Full Text] [Related]
5. Stenotrophomonas maltophilia: emergence of multidrug-resistant strains during therapy and in an in vitro pharmacodynamic chamber model.
Garrison MW; Anderson DE; Campbell DM; Carroll KC; Malone CL; Anderson JD; Hollis RJ; Pfaller MA
Antimicrob Agents Chemother; 1996 Dec; 40(12):2859-64. PubMed ID: 9124855
[TBL] [Abstract][Full Text] [Related]
6. Susceptibilities of 123 strains of Xanthomonas maltophilia to eight beta-lactams (including beta-lactam-beta-lactamase inhibitor combinations) and ciprofloxacin tested by five methods.
Pankuch GA; Jacobs MR; Rittenhouse SF; Appelbaum PC
Antimicrob Agents Chemother; 1994 Oct; 38(10):2317-22. PubMed ID: 7840563
[TBL] [Abstract][Full Text] [Related]
7. Stenotrophomonas (Xanthomonas) maltophilia: in vitro susceptibility to selected antimicrobial drugs, single and combined, with and without defibrinated human blood.
Traub WH; Leonhard B; Bauer D
Chemotherapy; 1998; 44(5):293-304. PubMed ID: 9732143
[TBL] [Abstract][Full Text] [Related]
8. A changing pattern of susceptibility of Xanthomonas maltophilia to antimicrobial agents: implications for therapy.
Vartivarian S; Anaissie E; Bodey G; Sprigg H; Rolston K
Antimicrob Agents Chemother; 1994 Mar; 38(3):624-7. PubMed ID: 8203865
[TBL] [Abstract][Full Text] [Related]
9. In vitro activities of beta-lactam-beta-lactamase inhibitor combinations against Stenotrophomonas maltophilia: correlation between methods for testing inhibitory activity, time-kill curves, and bactericidal activity.
Muñoz Bellido JL; Muñoz Criado S; García García I; Alonso Manzanares MA; Gutiérrez Zufiaurre MN; García-Rodríguez JA
Antimicrob Agents Chemother; 1997 Dec; 41(12):2612-5. PubMed ID: 9420028
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of antibiotic susceptibility of Stenotrophomonas maltophilia using a polyclonal antibody developed against an ABC multidrug efflux pump.
Al-Hamad A; Burnie J; Upton M
Can J Microbiol; 2011 Oct; 57(10):820-8. PubMed ID: 21942332
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial susceptibility of stenotrophomonas maltophilia isolates from Korea, and the activity of antimicrobial combinations against the isolates.
Chung HS; Hong SG; Kim YR; Shin KS; Whang DH; Ahn JY; Park YJ; Uh Y; Chang CL; Shin JH; Lee HS; Lee K; Chong Y
J Korean Med Sci; 2013 Jan; 28(1):62-6. PubMed ID: 23341713
[TBL] [Abstract][Full Text] [Related]
12. Activities of three quinolones, alone and in combination with extended-spectrum cephalosporins or gentamicin, against Stenotrophomonas maltophilia.
Visalli MA; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1998 Aug; 42(8):2002-5. PubMed ID: 9687397
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility of Stenotrophomonas maltophilia clinical strains in China to antimicrobial combinations.
Hu LF; Gao LP; Ye Y; Chen X; Zhou XT; Yang HF; Liiu YY; Mei Q; Li JB
J Chemother; 2014 Oct; 26(5):282-6. PubMed ID: 24588423
[TBL] [Abstract][Full Text] [Related]
14. The antibiotic susceptibilities of Xanthomonas maltophilia and their relation to clinical management.
Smit WJ; Boquest AL; Geddes JE; Tosolini FA
Pathology; 1994 Jul; 26(3):321-4. PubMed ID: 7991292
[TBL] [Abstract][Full Text] [Related]
15. In vitro susceptibility of 124 Xanthomonas maltophilia (Stenotrophomonas maltophilia) isolates: comparison of the agar dilution method with the E-test and two agar diffusion methods.
Arpi M; Victor MA; Mortensen I; Gottschau A; Bruun B
APMIS; 1996 Feb; 104(2):108-14. PubMed ID: 8619912
[TBL] [Abstract][Full Text] [Related]
16. In vitro activities of antimicrobial combinations against clinical isolates of Stenotrophomonas maltophilia.
Liaw SJ; Teng LJ; Hsueh PR; Ho SW; Luh KT
J Formos Med Assoc; 2002 Jul; 101(7):495-501. PubMed ID: 12353342
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic susceptibility profile of Xanthomonas maltophilia. In vitro activity of beta-lactam/beta-lactamase inhibitor combinations.
García-Rodríguez JA; García Sánchez JE; García García MI; García Sánchez E; Muñoz Bellido JL
Diagn Microbiol Infect Dis; 1991; 14(3):239-43. PubMed ID: 1889176
[TBL] [Abstract][Full Text] [Related]
18. Comparative in vitro activities of piperacillin-tazobactam and ticarcillin-clavulanate.
Fass RJ; Prior RB
Antimicrob Agents Chemother; 1989 Aug; 33(8):1268-74. PubMed ID: 2552904
[TBL] [Abstract][Full Text] [Related]
19. Levofloxacin Efflux and smeD in Clinical Isolates of Stenotrophomonas maltophilia.
Chong SY; Lee K; Chung HS; Hong SG; Suh Y; Chong Y
Microb Drug Resist; 2017 Mar; 23(2):163-168. PubMed ID: 27294684
[TBL] [Abstract][Full Text] [Related]
20. Susceptibilities of 200 penicillin-susceptible and -resistant pneumococci to piperacillin, piperacillin-tazobactam, ticarcillin, ticarcillin-clavulanate, ampicillin, ampicillin-sulbactam, ceftazidime, and ceftriaxone.
Pankuch GA; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1994 Dec; 38(12):2905-7. PubMed ID: 7695281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
